Company profile
Daxor Corporation
NASDAQ: DXR · Healthcare · Medical - Instruments & Supplies
#837 of 1,420 Healthcare companies by revenue33rd-percentile growth
EA Score
——FH —DQ —GM —SS 68
v0.1 · 5/100 weight · pillars only
↑ Altman-Z, listing tenure · ↓ disclosure history, net margin
Methodology →Revenue TTM
$917.3k
Rev growth YoY (TTM)
+132.2%
Net income (FY)
-$7.2M
Employees
37
as of 2026-08-19
Market cap
$60.1M
as of 2026-08-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.4M$1.4M2011
Net income-$7.2M-$7.2M2011
Operating income-$5.8M-$5.8M2011
Total assets$85.7M$85.7M2011
Liabilities$49.5M$49.5M2011
Equity$36.2M$36.2M2011
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Daxor Corporation’s revenue?
Daxor Corporation booked $1.4M in FY2011 revenue, contracting 8.4% year over year — slower than 67% of Healthcare companies we track, at a -496.8% net margin.
Peers · Healthcare
Xsovt Brands, Inc.——Glow Lifetech Corp.——American Green, Inc.51DPerspective Therapeutics, Inc.46DBraxia Scientific Corp.——Outlook Therapeutics, Inc.22DKey facts
CEOMichael Richard Feldschuh
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersOak Ridge, TN
ExchangeNASDAQ: DXR
Employees37
IPO date1983-07-25
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.